Effect of tri-0-tolyl phosphate pretreatment on the toxicity and metabolism of parathion and paraoxon in mice.
D000115:Acetylesterase / Q000097:blood / Q000378:metabolism; D000818:Animals; D001921:Brain / Q000201:enzymology; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D002802:Cholinesterases / Q000378:metabolism; D003408:Cresols / Q000494:pharmacology*; D006591:Hexobarbital / Q000494:pharmacology; D007408:Intestinal Absorption / Q000187:drug effects; D007422:Intestines / Q000201:enzymology; D007928:Lethal Dose 50; D008099:Liver / Q000201:enzymology; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D008862:Microsomes, Liver / Q000201:enzymology; D009943:Organophosphorus Compounds / Q000494:pharmacology* / Q000633:toxicity*; D010088:Oxidoreductases / Q000378:metabolism; D010261:Paraoxon / Q000378:metabolism / Q000633:toxicity; D010278:Parathion / Q000378:metabolism / Q000633:toxicity*; D012890:Sleep / Q000187:drug effects; D013997:Time Factors
D002800:Cholinesterase Inhibitors; D003408:Cresols; D009943:Organophosphorus Compounds; D010278:Parathion; D006591:Hexobarbital; D010088:Oxidoreductases; D000115:Acetylesterase; D002802:Cholinesterases; D010261:Paraoxon